Showing results (821-830 of 6,955) with videos related to
Sort By:
Pageof 696
Journal of Clinical Pharmacology|February 1, 1992
Diurnal effect on caffeine clearanceM Hashiguchi, A Fujimura, K Ohashi, et al.Journal of Clinical Pharmacology|March 1, 1992
Single-dose pharmacokinetics of ibuprofen and acetaminophen in febrile childrenR D Brown, J T Wilson, G L Kearns, et al.Journal of Clinical Pharmacology|June 17, 2004
Simulation of the impact of atropisomer interconversion on plasma exposure of atropisomers of an endothelin receptor antagonistY S Zhou, L K Tay, D Hughes, et al.Journal of Clinical Pharmacology|June 17, 2004
Effects of a new antibacterial, telavancin, on cardiac repolarization (QTc interval duration) in healthy subjectsSteven Barriere, Fredric Genter, Elizabeth Spencer, et al.Journal of Clinical Pharmacology|June 17, 2004
Pharmacokinetic study of mycophenolic acid in Korean kidney transplant patientsEun Kyung Cho, Duck Jong Han, Song Cheol Kim, et al.Journal of Clinical Pharmacology|June 17, 2004
Lack of interaction between enfuvirtide and ritonavir or ritonavir-boosted saquinavir in HIV-1-infected patientsKiat Ruxrungtham, Mark Boyd, S Eralp Bellibas, et al.Journal of Clinical Pharmacology|August 20, 2004
Ibandronate: a clinical pharmacological and pharmacokinetic updateJoanne Barrett, Eric Worth, Frieder Bauss, et al.Journal of Clinical Pharmacology|August 20, 2004
Possible induction of cholinesterase in epileptic patients treated with anticonvulsant drugs: relationship with lipoprotein levelsMaría J Tutor-Crespo, Jesús Hermida, J Carlos TutorJournal of Clinical Pharmacology|August 20, 2004
Simvastatin does not have a clinically significant pharmacokinetic interaction with fenofibrate in humansArthur J Bergman, Gail Murphy, Joanne Burke, et al.Journal of Clinical Pharmacology|June 14, 2005
The effects of NN414, a SUR1/Kir6.2 selective potassium channel opener, in healthy male subjectsMilan Zdravkovic, Matthias Kruse, Karl Ludwig Rost, et al.Pageof 696